- Sputnik International, 1920
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

Montenegro Negotiates Supply of Russia's Sputnik V Vaccine With Moscow, Health Ministry Says

© Sputnik / Hungarian Foreign Ministry / Go to the mediabankIn this handout photo released by Hungarian Foreign Ministry, a laboratory assistant holds a phial with Russia's coronavirus vaccine Gam-COVID-Vac, trade-named Sputnik V, in Budapest, Hungary
In this handout photo released by Hungarian Foreign Ministry, a laboratory assistant holds a phial with Russia's coronavirus vaccine Gam-COVID-Vac, trade-named Sputnik V, in Budapest, Hungary - Sputnik International, 1920, 16.02.2021
Subscribe
BELGRADE (Sputnik) - Montenegro is negotiating delivery of Russia's Sputnik V coronavirus vaccine with the Russian government and Moscow's Gamaleya Epidemiology and Microbiology Center, the country's health ministry told Sputnik on Tuesday.

Montenegro has yet to start vaccinating its citizens against the disease as tit has not yet received any vaccines. earlier in the day, the country detected seven cases of the UK strain of the virus out of 40 samples, sent to Berlin for analysis.

"The Health Ministry of Montenegro is discussing COVID-19 vaccine supply with the Russian government's negotiation team, which includes an expert group from the Gamaleya Center, the manufacturers of the Sputnik V vaccine," the ministry said, adding the information on the results will be made public after the end of the talks.

Since the beginning of the pandemic, Montenegro has confirmed a total of 69,294 cases, including 899 deaths. The country's entire population is about 620,000 people.

Laboratory workers work in the pilot production phase of Russia's Sputnik V Coronavirus vaccine for COVID-19 at the pharmaceutical company Uniao Quimica in Brasilia, Brazil, Monday, Jan. 25, 2021. - Sputnik International, 1920, 16.02.2021
Germany’s Economic Affairs Minister Congratulates Russia on Success of Sputnik V Vaccine

The Russian vaccine, developed by the Gamaleya Epidemiology and Microbiology Center and registered by the Russian Ministry of Health on August 11, was the world's first vaccine against the coronavirus.

In February, peer-reviewed medical journal The Lancet published an interim analysis from the phase 3 trial of the Russian vaccine, showing its 91.6-percent efficacy against symptomatic COVID-19. The vaccine has already been approved in various countries across the globe, including Belarus, Serbia, Argentina, Bolivia, Mexico, Nicaragua, Algeria, Lebanon, Palestine, Venezuela, Paraguay, Hungary, the UAE and others.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала